Cellectis
CLLS
#9651
Rank
NZ$0.20 B
Marketcap
NZ$1.99
Share price
4.67%
Change (1 day)
-68.50%
Change (1 year)

Operating Margin for Cellectis (CLLS)

Operating Margin as of November 2026 (TTM): -116.06%

According to Cellectis's latest financial reports and stock price the company's current Operating Margin is -116.06%. At the end of 2021 the company had an Operating Margin of -218.37%.

Operating Margin history for Cellectis from 2015 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-218.37%65.65%
2020-131.82%-82.62%
2019-758.47%9.32%
2018-693.83%68.55%
2017-411.65%174.26%
2016-150.10%270.93%
2015-40.46%-572.78%
20148.56%-102.41%
2013-355.39%254.63%
2012-100.21%-17.36%
2011-121.26%72.35%
2010-70.36%3.98%
2009-67.66%171.31%
2008-24.94%-85.33%
2007-169.96%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Regeneron Pharmaceuticals
REGN
33.25%-128.65%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
-1,313.03% 1,031.34%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
39.35%-133.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-31.87%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.